AHI AR 2011 Final web version

Animal Health Ireland

Annual Report 2011


page 3

Chairman’s Address Chief Executive Officer’s Report


page 6

Stakeholders & Members Board Implementation Team Technical Working Groups

SECTION 3 Corporate Governance

page 17

Legal Financial Performance Monitoring

SECTION 4 Disease Programmes

page 20

BVD CellCheck

SECTION 5 Financial Report

page 24

PAGE 1 Annua l R e p or t 2011



PAGE 3 Annua l R e p or t 2011

Chairman’s address Having put emphasis on structure and planning over the past two years, Animal Health Ireland has now moved firmly into the delivery phase. We have identified four programmes (BVD, CellCheck , Johne’s disease and IBR), which we will absorb most of our resources over the coming years, together with a number of other programmes (parasite control, CalfCare and biosecurity), which are important but which will impact less on our time and resources. The chairs and members of both the technical and implementation groups deserve the gratitude of the agricultural industry for their contribution to this work. BVD is the most visible of our programmes. We are moving very successfully through a voluntary phase of BVD control and are busy planning for a national eradication programme, starting on January 1st 2013. It is good to see so many sectors of the industry, the scientific and research community, service providers and the state working in harmony for BVD eradication. We are also in dialogue with Northern Ireland and expect that these talks will result in benefits for both jurisdictions in relation to BVD eradication and Johne’s disease control. I am delighted with the publication of the CellCheck Farm Guidelines on Mastitis Control. However, very much more activity on this programme has been taking place behind the scenes where we have been building the capacity to deliver an extensive national programme. CellCheck has the potential to deliver very significant savings to both the producer and the processor and inter-organisational co-operation is, once again, a key component of the programme. A large number of stakeholders, service providers and individuals support Animal Health Ireland in many ways, ranging from financial support to service provision and technical input. While we interact with them regularly, we would welcome the thoughts and opinions of these groups as to how we can make this bond even stronger. The Board, CEO and staff at AHI continue to give me great support and encouragement, which I am delighted to have the opportunity to publicly acknowledge.

Mike Magan, Chairman, AHI

PAGE 4 An i ma l H e a lt h I r e l and

Chief Executive Officer’s report Over the course of 2011, Animal Health Ireland has continued the process of consolidating its position as the national organisation with responsibility for the development of eradication, control and awareness-raising programmes for the major non-regulated diseases of livestock. This has been accompanied by an increasing recognition of the role that continued improvements in Ireland’s animal health status, together with those in the fields of nutrition and breeding, can make in underpinning the sustainability, competitiveness and profitability of the industry. Acknowledgement of the important role of AHI is reflected in documents such as Food Harvest 2020, the medium-term strategy for the development of the agri-food industry, and in the recent research calls issued by the Department of Agriculture, Food and the Marine. Two of these programmes – the BVD eradication programme and CellCheck – reached the end of their respective planning phases in 2011 and moved into an implementation phase in 2012. Elsewhere in this Report, the Programme Managers – David Graham and Finola McCoy – outline the progress achieved in relation to these programmes in the period under review. However, it is worth highlighting here some of the notable achievements of each programme at the time of writing. In relation to the BVD eradication programme, some 9,500 suckler and dairy farmers have purchased over 560,000 button tags, and some 375,000 results have already been processed, of which about 0.6% have tested positive. Good progress continues to be made by the BVD Implementation Group in preparation for the compulsory phase of the programme from January 2013. In the case of the CellCheck programme, the successful launch in February of the Farm Guidelines for Mastitis Control, and their subsequent strong uptake by AHI stakeholders, was followed by Stage 1 of the programme of capacity-building for service providers, some 400 of whom have attended these events to date. A solid foundation has now been established for the next stages of the programme, which will involve further, more sophisticated engagement with service providers and the beginning of direct interaction with dairy farmers. In the area of corporate governance and development, a significant development in 2011 was the establishment of a Planning Group, comprising AHI Stakeholders and an external consultant, with the objective of developing a strategy to guide AHI over the next three years. The outcome of that process, the AHI Strategic Plan (2012-2014), was adopted by the Board of AHI in February of this year and was subsequently published and distributed to stakeholders and key decision-makers in the sector. We now have a clear blueprint to guide our work over the coming years and have developed and published detailed Business Plans for each of the four priority programmes (BVD, CellCheck , Johne’s disease and IBR) identified in the Strategic Plan. Conscious of the expectations on the part of all our funders for delivery in relation to the programmes with which we have been entrusted, I look forward to reporting continued good progress over the coming years in relation to all aspects of the work programme set out in the Strategic Plan.

Joe O’Flaherty, Chief Executive, AHI

PAGE 5 Annua l R e p or t 2011


The Company Animal Health Ireland (AHI) is an industry-led, not-for-profit partnership between livestock producers, processors, animal health advisers and government. Its remit includes diseases and conditions of livestockwhich are endemic in Ireland, but which are not currently subject to regulation and coordinated programmes of control. AHI is a Company Limited by Guarantee and not having a Share Capital, incorporated as such under the Companies Acts (1963-2006) on 11th May 2009. The Memorandum and Articles of Association of the Company are available to view on the AHI website. As a not-for-pro t Company, AHI operates on the principle that the nancial contribution from Stakeholders in any given year should be set, insofar as is possible, and having regard to the need to maintain adequate levels of working capital, so as to match forecast expenditure. The largest single financial contribution to the Company is made by the Department of Agriculture, Food and the Marine, which, in 2009, committed to provide AHI a maximum amount of €500,000 per annum for a period of 5 years, subject to the receipt of a matching contribution by non-State sources, and to the provisions made in the Annual Estimates of Public Expenditure. In establishing the level of contribution by individual private sector Stakeholders, account is taken of the size of the organisation and of the nature of the business in which it is engaged. Stakeholders and Members The Stakeholders are the various organisations that set the overall strategic direction of the organisation and that provide the necessary financial and other resources to enable Animal Health Ireland to operate effectively. In 2011, a process of formalising membership of Animal Health Ireland was begun and all Stakeholder organisations were invited to submit applications for membership of the Company. Members have entitlement to vote at General Meetings, and where voting by poll takes place, each Member is entitled to one ‘Contribution Vote’ in respect of every €3,000 of Annual Financial Contribution to the Company (see also Section 3). As of 31st December 2011, the following organisations were Members and/or Stakeholders in Animal Health Ireland (*indicates membership). The Register of Members is available to view from theMember Area of the AHI website.

PAGE 7 Annua l R e p or t 2011

Farmers’ organisations Irish Cattle and Sheep Farmers’ Association (ICSA)* Irish Charolais Cattle Society Irish Co-operative Organisation Society (ICOS) Irish Creamery Milk Suppliers’ Association (ICMSA)* Irish Farmers’ Association (IFA)* Irish Holstein Friesian Association* Macra na Feirme* Pedigree Cattle Breeders’ Council of Ireland* Dairy and Beef Processors AIBP* Arrabawn Co-op*

Carbery Group* Connacht Gold* Dairygold Co-op* Dawn Meats* Glanbia* Kepak Group* Kerry Agribusiness* Lakeland Dairies* Tipperary Co-op*

Town of Monaghan Co-op Wexford Milk Producers* Government and State Agencies Bord Bia* Department of Agriculture, Food and the Marine* Teagasc* Professional/Advisory/Support services Cork Marts* DAFM – Veterinary Lab Services* ICBF* Irish Dairy Board UCD Veterinary Ireland*

PAGE 8 An i ma l H e a lt h I r e l and

Board The Board of Animal Health Ireland comprises seven non-executive Directors, nominated by the Minister for Agriculture at the time of the establishment of the organisation. The Directors, collectively, have expertise and experience in the following fields:

• beef and dairy livestock production • industry processing and marketing • animal health services and their delivery • major export markets for livestock and their products; and • agricultural policy development.

During the year, the Directors of Animal Health Ireland were:


Date of appointment

May 2009 May 2009 May 2009 May 2009 May 2009 May 2009 May 2009

Mr. Mike Magan, Chairman (Dairy Farmer) Mr. Gerard Brickley (Bord Bia)

Mr. Joe Collins (Irish Dairy Board) Professor Michael Doherty (UCD) Ms. Thia Hennessy (Teagasc)* Mr. John O’Sullivan (Dairy Farmer) Mr. Robin Talbot (Beef Farmer)

* Ms. Hennessy retired from the Board of AHI on 3 rd July 2011.

Directors’ remuneration Directors of AHI who are public servants are precluded from drawing an Honorarium from the Company under the ‘one person one salary’ principle 1 ; three of the Directors serving in 2011 were precluded from receiving fees from Animal Health Ireland on this basis. The payment of fees to those Directors eligible to receive them is subject to compliance with the Code of Practice for the Governance of State Bodies 2 , and fees are subject to taxation. Annual Report 2011 – Implementation Team At 31st December 2011, the permanent staff of Animal Health Ireland comprised the following:



Date of employment

Mr. Joe O’Flaherty Ms. Nuala Morgan Dr. David Graham Mr. Karol Harvey Ms. Fionnuala Malone

Chief Executive Officer Company Secretary Programme Manager (Biosecure Diseases)

24/09/09 08/03/10 01/10/10 29/11/10 16/03/11

Planning & Operations Manager Technical Working Group Liaison

1 Established by the Review Body on Higher Remuneration in the Public Service (1972). 2 As approved in October 2001 (Appendix D).

PAGE 9 Annua l R e p or t 2011

Finola McCoy ( CellCheck Programme Manager) In addition to the staff directly employed by the Company, AHI has entered into a Collaboration Agreement with Teagasc, under which the latter has undertaken to assign a member of its staff, Ms. Finola McCoy, in the capacity of Programme Manager for the national mastitis control programme, CellCheck . Technical Working Groups The Technical Working Groups (TWGs) comprise experts and experienced practitioners from a variety of fields who are tasked with drawing up factual resources, the development of decision-making tools, and the identification of areas for further Research and Development. Furthermore, in areas in which AHI is developing disease control and eradication programmes of national scope, the TWGs also provide the technical support necessary to underpin such programmes. By giving of their time free of charge, these experts enable AHI access the technical resources required to develop its various programmes at a fraction of the true commercial cost of such expertise. Animal Health Ireland gratefully acknowledges the generosity of these individuals and that of their parent organisations and employers. Chairs of the Technical Working Groups As of 31 st December 2011, seven Technical Working Groups, comprising a total of 58 members and chaired by the individuals listed below, were operational and had met on at least one occasion over the course of 2011.

Dr. Michael Doherty is Professor of Veterinary Clinical Studies in the School of Agriculture, Food Science and Veterinary Medicine, University College Dublin. A graduate of the University of Edinburgh, his background is in cattle practice in Donegal and at the Farm Animal Unit of the University of Glasgow. He has managed many clinical research programmes, including studies of herd health in conventional and organic dairy herds and published extensively in clinical aspects of farm animal health. A past-President and board member of the European College of Bovine Health Management, he is actively involved along with colleagues in the UCD Herd Health Group in the promotion, development and implementation of herd health in Ireland. Dr. Ingrid Lorenz (UCD) is originally from a dairy farm in Southern Germany and joined the UCD Herd Health Group in April 2007 as Lecturer in Bovine Medicine. She graduated from the Veterinary School of the University of Munich in 1992 after which she prepared her doctoral thesis in the area of calf diseases at the Clinic for Ruminants of the University. She subsequently took up a lecturer position at the Clinic and was awarded a PhD in 2007. Her qualifications include Dr. med. vet., Dr. med. vet. habil., Dip. ECBHM. Over the course of her career to date Ingrid has acquired vast experience in internal medicine and surgery as well as in the investigation of calf-related herd health problems.

PAGE 10 An i ma l H e a lt h I r e l and

Dr. JohnMee (Teagasc ) is originally from a farm in Co. Roscommon and now lives in Fermoy, Co. Cork where he works with Teagasc in the Moorepark Research Centre. He graduated from UCD with an MVB and a PhD in Veterinary Medicine, and is a Veterinary Council of Ireland accredited Veterinary Practitioner and a European College Specialist in bovine health. He has over 25 years’ experience in leading dairy and beef, cow and calf, health, welfare and reproduction research programmes. John has worked in research institutes, universities, the Department of Agriculture and in private veterinary practice in Ireland, New Zealand and in Australia. His current research interests include dairy cow and calf herd health and fertility and beef herd health. His research work has been published in over 75 scientific papers in peer-reviewed journals and textbooks. He also reviews for over 20 leading international bioscience journals and serves on the editorial boards of five scientific journals, including the Irish Veterinary Journal BioMed Central (Deputy Editor). In addition to chairing the biosecurity TWG, John is also a member of four other AHI Technical Working Groups. Professor SimonMore is originally fromAustralia and is now based at University College Dublin. He qualified in 1984 from the University of Sydney. He is a Veterinarian with specialist skills in National and International animal disease control with the following qualifications: BVCs (Hons 1), MVB, PhD, MACVSc, FACVSc, DipPM, DiplECBHM, DiplECVPH. Simon has worked/consulted in a number of countries (Australasia, southeast Asia, Europe, South America) with both government and industry on national animal disease control issues. In Ireland, he is director of the Centre for Veterinary Epidemiology and Risk Analysis at University College Dublin, and with his fellow colleagues provides information to support national decision-making on animal disease control, by both government and industry

PAGE 11 Annua l R e p or t 2011

Technical Working Groups

Member Name Biosecurity TWG

4 meetings held between 1/2/2011 and 31/12/2011

Parent Organisation

Prof John Mee (Chair) Stephen Conroy

Teagasc Manager, Tully Bull Performance Centre, Kildare Intervet, Schering Plough National Cattle Breeding Centre Retired UCD AHI Veterinary Practitioner Technical Working Group Rapporteur AHI Central Vet Research Laboratory UCD DAFM, Veterinary Laboratory Services Veterinary Practitioner UCD DAFM, Veterinary Laboratory Services Intervet, Schering Plough National Cattle Breeding Centre AHI DAFM, Veterinary Laboratory Services Technical Working Group Rapporteur AHI Teagasc UCD Teagasc Veterinary Practitioner UCD Manager, Tully Bull Performance Centre, Kildare Munster AI Intervet, Schering Plough National Cattle Breeding Centre UCD AHI 1 meeting held between 1/2/2011 and 31/12/2011 Parent Organisation 2 meetings held between 1/2/2011 and 31/12/2011 Parent Organisation

Bosco Cowley Bernard Eivers Richard Fallon Tim Geraghty David Graham Pat Kirwan Fionnuala Malone John Moriarty Luke O’Grady Ronan O’Neill Michael Sexton


Member Name

Michael Doherty (Chair) Damien Barrett

Bosco Cowley Bernard Eivers David Graham Ronan O’Neill Fionnuala Malone John Mee Luke O’Grady Riona Sayers Michael Sexton


Member Name

Michael Doherty (Chair) Stephen Conroy Doreen Corridan

Bosco Cowley Bernard Eivers Tim Geraghty David Graham

PAGE 12 An i ma l H e a lt h I r e l and

IBR TWG (continued)

Member Name

Parent Organisation

Maria Guelbenzu Donal Lynch Fionnuala Malone Shane McElroy John Melville

AFBI NI Veterinary Practitioner Technical Working Group Rapporteur AHI Veterinary Practitioner DAFM Pfizer Animal Health DAFM, Veterinary Laboratory Services Teagasc UCD DAFM, Veterinary Laboratory Services Intervet, Schering Plough Teagasc UCD Merial Teagasc Veterinary Practitioner Veterinary Laboratory Services Technical Working Group Rapporteur AHI UCD CVRL DAFM DAFM UCD Pfizer Animal Health Teagasc DAFM, Veterinary Laboratory Services Retired Volac Ireland Veterinary Practitioner DAFM, Veterinary Laboratory Services Teagasc Technical Working Group Rapporteur AHI Teagasc Parent Organisation Parent Organisation

Mary Newman Ronan O’Neill Riona Sayers

Member Name Parasite Control

1 meeting held between 1/2/2011 and 31/12/2011

Michael Doherty (Chair) Michael Casey Bosco Cowley Martin Danaher

Theo De Waal Andrew Forbes Barbara Good Fintan Graham Ian Hogan Fionnuala Malone Grace Mulcahy

Tom Murphy Donal Toolan

Member Name CalfCare TWG

2 meetings held between 1/2/2011 and 31/12/2011

Ingrid Lorenz (Chair) Charles Chavasse Bernadette Earley John Fagan Richard Fallon Liam Gannon John Gilmore Ian Hogan Emer Kennedy Fionnuala Malone John Mee

PAGE 13 Annua l R e p or t 2011

Johne’s disease TWG

5 meetings held between 1/2/2011 and 31/12/2011

Member Name

Parent Organisation

Member Name CellCheck TWG Simon More (Chair) Damien Barrett Jim Buckley Bill Cashman Richard Fallon Margaret Good David Graham Kevin Kenny Fionnuala Malone John Mee Ciaran Mellett Peter Mullowney Samuel Strain Paul Whyte Simon More (Chair) Willie Buckley Don Crowley Brendan Dillon Kevin Downing Edmond Harty Alan Johnson Patrick Kelly Fionnuala Malone Finola McCoy Luke O Grady Frank O Sullivan George Ramsbottom Tom Ryan

UCD DAFM, Veterinary Laboratory Services Cork County Council Veterinary Practitioner Retired DAFM AHI CVRL, DAFM Techncial Working Group Rapporteur AHI Teagasc Veterinary Practitioner DAFM AFBI NI UCD

2 meetings held between 1/2/2011 and 31/12/2011

Parent Organisation

UCD Riverview Veterinary Clinic

Teagasc Glanbia ICBF HerdPlus Dairymaster DAFM Veterinary Laboratory Services Munster AI Technical Working Group Rapporteur AHI AHI / Teagasc UCD Veterinary Practitioner

Teagasc Teagasc

PAGE 14 An i ma l H e a lt h I r e l and

Implementation Groups

Implementation Groups for the BVD eradication programme and for CellCheck , the two programmes of national scope which have reached implementation phase, were established over the course of 2011. BVD Implementation Group

Member Name BVD Implementation Group

15 meetings held between 1/2/2011 and 31/12/2011 Parent Organisation

Joe O’Flaherty (Chair) Michael Biggins Martin Blake Tomás Bourke


Pat Brangan Louis Byrne

DAFM PCBCI DAFM ICBF UCD, Chair of BVD TWG Teagasc ICOS Veterinary Practitioner PCBI Programme Manager, AHI AHI Veterinary Ireland Veterinary Practitioner ICMSA PCBI Veterinary Ireland IFA DAFM IFA

Micheal Casey Sean Coughlan Michael Doherty John Donworth Ray Doyle Conor Geraghty Peadar Glennon David Graham Karol Harvey Pat Kirwan Donal Lynch Pat McCormack John McEnroe John O’Roarke Tom Phelan Donal Sammin Richard Whelan

PAGE 15 Annua l R e p or t 2011

Member Name CellCheck Industry Consultation Group 6 meetings held between 1/2/2011 and 31/12/2011 Parent Organisation Mike Magan, Chair

AHI Carbery DAFM Irish Farmers’ Journal Glanbia Kerry Agribusiness Lakeland Dairies Coyle Veterinary ACA Wexford Milk Producers Teagasc ICMSA

Paddy Barrett Martin Blake John Boylan Anne Browne Kieran Collins Dermot Coyle Michael Coyle Martin Crowe Michael Daly Pat Dillon John Enright Paul Fortune Paul Hoare Karol Harvey

Tipperary Co-op Irish Dairy Board AHI IMQCS Irish Farmers’ Journal Veterinary Ireland IFA ICMSA Programme Manager UCD, Chair of CellCheck TWG

George Kearns Jack Kennedy Pat Kirwan Catherine Lascurettes Pat McCormack Finola McCoy Simon More Bernadette O’Brien Tom O’Dwyer Liam O’Flaherty Jerry Ryan

Teagasc Teagasc Dairygold Arrabawn Co-op Carbery Connacht Gold ICBF

Sinead Treanor Anthony Walsh Brian Wickham

PAGE 16 An i ma l H e a lt h I r e l and


The Second Annual General Meeting of the Company was held in Portlaoise on 30th June 2011. In addition to the ordinary business of the AGM, Members received briefings from the Chairman on the ongoing review of governance; from the CEO on delivery against the 2011 Business Plan; from Dr. David Graham on progress in relation to the biosecure diseases (BVD, Johne’s disease and IBR); and from Ms. Finola McCoy in relation to the CellCheck programme. The first Extraordinary General Meeting (EGM) of the Company was also held on 30 th June 2011 to consider a number of Special Resolutions, presented by the Board of Directors. These Special Resolutions proposed certain amendments to the Memorandum and Articles of Association, respectively, of the Company, designed to give effect inter alia to the recommendations made by an ad hoc group, convened to review existing governance arrangements. The objective of the review was to enhance the ability of the organisation to achieve its business goals on behalf of stakeholders and to ensure compliance with its legal and ethical obligations. The principal proposals contained in the Special Resolution on the Articles of Association related to: alterations to the composition of the Board to allow for the direct representation thereon of Members; the creation of a Planning Group; the establishment of an Audit, Finance and Risk Committee. However, following discussion and in the absence of general agreement on the matters in question, the meeting was closed without proceeding to take a vote on the Special Resolutions. The second EGM was held in Portlaoise on 29 th September. In addition to the Special Resolutions presented at the first EGM, two further Special Resolutions, proposed by IFA and ICMSA respectively, were presented 3 . However, as with the first EGM, the absence of general agreement meant that the meeting was closed without proceeding to a vote. Voting at General Meetings Voting at any General Meeting is generally by a show of hands of the Stakeholders present. However, the Articles of Association also establish a mechanism – known as a poll – under which a Stakeholder’s vote may be weighted by reference to the amount of the Annual Financial Contribution of that Stakeholder to the Company. Board meetings The Board met on three occasions between 1/2/2011 and 31/12/2011. The attendance of Directors at these meetings is summarised below:


Meetings attended

M. Magan G. Brickley J. Collins M. Doherty T. Hennessy J. O’Sullivan R. Talbot

3 2 2 3 1 1 1

3 Copies of all Special Resolutions are available to view from the Members’ Area of the AHI website.

PAGE 18 An i ma l H e a lt h I r e l and

Conflict of interest Any Director who is any way directly or indirectly interested in a contract or proposed contract with the Company is obliged to declare the nature of that interest at a meeting of the Directors in accordance with Section 194 of the Companies Act (1963). Directors may not vote in respect of any contract in which they have an interest. Subject to due disclosure, however, a Director may be directly or indirectly interested in a contract or arrangement with the Company, with the exception of any of ce or employment with the Company. Directors may not be employees of the Company. Committees The only committee currently constituted by the Directors is the Remuneration Committee, which was first convened on 5 th February 2010. The members of the Remuneration Committee are Mr. John O’Sullivan (Chairman), Mr. Joe Collins, Mr. Robin Talbot and Mr. Joe O’Flaherty. No meetings of the Remuneration Committee took place in the period covered by this report. Terms of Reference for this Committee are available to Members from the AHI website. Memoranda of Understanding Memoranda of Understanding have been developed between AHI and the organisations listed below. These memoranda are available for inspection by Members upon request and from the AHI website.


Date of entry into force

Department of Agriculture, Food and the Marine Teagasc Agri-Food & Biosciences Institute Glanbia

14/06/2010 01/09/2010 22/09/2010 03/06/2011

Performance monitoring Directors and other Members have access to a wide range of information on the performance of the Company, in addition to that provided at meetings of the Board and Members. This information, which is available from the AHI website, includes: agendas and Minutes of Board and Member meetings; Management Accounts (quarterly); newsletters (quarterly); and compliance reports (quarterly).

PAGE 19 Annua l R e p or t 2011


Space restrictions preclude the provision here of comprehensive reviews of all of the work programmes and the following summary is therefore confined to those programmes of national scope which had proceeded to an implementation phase as of 31 st December 2011. Regular updates on these and all other programmes are provided in the quarterly newsletters, which are available from the AHI website. BVD

Dr. David Graham, Programme Manager for the biosecure diseases

The BVD Implementation Group, supported by the Technical Working Group on BVD, met frequently following its inaugural meeting in June 2011. Meetings focussed on the planning and communication of the programme in the lead-in to the launch of the voluntary phase of the programme in January 2012. Key areas of activity included: • Design of the programme, with an emphasis on tag testing of calves. Programme guidelines for participating farmers were agreed and protocols for re-testing calves with non-negative results established. • The development of a technical exercise (TE) for laboratories wishing to be designated to provide test results for the programme. This was delivered by the Central Veterinary Research Laboratory (CVRL) on behalf of the BVDIG and assessed the ability of laboratories to test ear punch samples for BVD virus by either ELISA or RTPCR methods and to successfully transfer results to the ICBF database. Arising from the TE and the initial call for applications in August, five laboratories were designated by the BVDIG, with the process remaining open to other laboratories to apply subsequently. • The development by ICBF, under the guidance of Dr. David Graham, of a database capable of receiving test results from the designated laboratories and reporting these to herd owners by SMS message. Supplementary letters, to be issued when calves produced positive or inconclusive results (or when the tag did not contain tissue) were also agreed and built into the reporting cycle. The ability to communicate these results to purchasers at the point of sale through farmer-generated declarations of negative results was also established, and work commenced on transferring results to mart electronic display boards. • Completion of a cost-benefit study on eradication of BVD in Ireland. This suggested annual losses of €102M, with a clear benefit:cost ratio of approximately 10:1 over an anticipated six-year programme. This work was presented as part of an Economics Workshop held in July 2011 and will be published in a peer-reviewed journal over the course of 2012. • Development and implementation of a contingency plan to use a third ‘button’ tag to collect the ear punch sample. This followed on from the decision by DAFM, that it would not be possible to award a tender for the provision of tissue sample-enabled official ID tags for use in 2012.

PAGE 21 Annua l R e p or t 2011

• Development and implementation of a comprehensive communication strategy to promote knowledge and awareness of the voluntary phase of the programme, which was launched by Minister Coveney at the Ploughing Match on 21 st September. The launch was followed by an intensive communication effort over the remainder of the year, including attendance at a series of open days and conferences, such as the Cattle Association of Veterinary Ireland conference and the Teagasc dairy conference. In addition, a series of sixteen information evenings were held around the country in November and December, comprising presentations from veterinary practitioners on BVD, farmers on their personal experiences of BVD and from AHI on the programme itself. A series of articles was published in the farming press and the Irish Veterinary Journal, and guidance documents for farmers and vets were developed. DVDs promoting and explaining the programme were also prepared and displayed in marts. • Developing links with veterinary and farm organisations in Northern Ireland to encourage an all- island, industry-led approach to the control of non-regulated diseases, with an initial focus on BVD. Presentations were made to veterinary organisations and DARD. Dr. David Graham represented BVDIG at several meetings of a Cattle Health Steering Group convened by the Ulster Farmer’s Union. This group is actively seeking to put in place a BVD eradication programme in Northern Ireland that mirrors the approach being taken by the BVDIG.


Finola McCoy, Teagasc, CellCheck Programme Manager

• A pilot series of Farmer Workshops was delivered in June and July 2011. 9 workshops were held, one in each stakeholder (milk processor) region, and almost 100 farmers participated. The objective of the workshop was to deliver best science and practice information around mastitis control to farmers, and to encourage the uptake of key best practices in everyday milking routines. The workshops, which contained a mix of theory and activity, allowed farmers to assess their current practices and to gain an understanding of the potential economic gains from improving mastitis control. Evaluation of the pre-pilot survey showed that while the reported rate of implementation of key practices (e.g. post-milking teat disinfection) is high, the standard to which these practices is carried out is generally quite low. • Following each farmer workshop, an information evening was held for all service providers in that region. These multidisciplinary events provided an opportunity for professionals to meet colleagues working in the same region, to learn about the workshops that some of their own clients may have participated in and to find out how they might get involved in CellCheck activities in the future.

PAGE 22 An i ma l H e a lt h I r e l and

• Final development work on the production of the CellCheck Farm Guidelines for Mastitis Control . These are practical, evidence-based best practice recommendations to assist mastitis control, supportedby the latest scienceand research. This resourcewas developedas a result of collaboration between AHI and Dairy Australia, which provided AHI with access to the technical resource developed by Dairy Australia in support of the CountDown Downunder national programme. The CellCheck Technical Working Group took on the task of reviewing this material and adapting it for use in Ireland, in the process incorporating feedback from the Industry Consultation Group. This manual is designed to be a practical guide to effective mastitis control, divided into five key stages of the cow’s lactation cycle, for use by farmers and service providers alike. • Research by Teagasc into the economic impact of elevated SCC continued in 2011, and a scientific paper has been submitted for peer-review publication. This paper, which is of considerable importance to the CellCheck programme, demonstrates the impact of SCC on farm profitability in Ireland. It will be used as a tool to build awareness of the economic opportunities arising from improved mastitis control. • A detailed planning exercise, involving representatives from Dairy Australia, was carried out to map out the 2012 phase of the CellCheck Programme. This included reviewing the work done to date, identifying the objectives for 2012 and outlining the activities to achieve these objectives. The CellCheck Business Plan (2012) and the CellCheck Programme Briefing Document (2012), both of which are available from the AHI website, reflect the outcomes of the planning exercise.

PAGE 23 Annua l R e p or t 2011

SECTION 5: FINANCIAL REPORT Animal Health Ireland Initiative Period Ended 31 st December 2011



Directors and Other Information


Directors’ Report


Independent Auditors’ Report


Income and Expenditure Account


Balance Sheet


Cashflow Statement


Accounting Policies


Notes to the Financial Statements


PAGE 25 Annua l R e p or t 2011

Directors and Other Information

Board of Directors M. J. Magan (Chairman)

J. G. Brickley J. O’Sullivan L. J. Collins M. L. Doherty R. Herbert Talbot Secretary and Registered Office N. Morgan Main Street, Carrick-on-Shannon, Co. Leitrim. Registered Number 470675 Solicitors Frank Mulvey Solicitors, Castle Building, Friary Road, Naas, Co. Kildare. Auditors Spain, Fewer, Quinlan & Co., Chartered Accountants & Registered Auditors, The Mall, Thurles, Co. Tipperary. Bankers Bank of Ireland, Carrick-on-Shannon, Co. Leitrim

PAGE 26 An i ma l H e a lt h I r e l and

Directors’ Report

The directors present herewith the audited financial statements for the year ended 31 st December 2011. Statement of Directors’ Responsibilities The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and generally accepted accounting practices in Ireland including the accounting standards issued by the Accounting Standards Board and published by the Institute of Chartered Accountants in Ireland. Irish company law requires the directors to prepare financial statements for each financial year which give a true and fair view of the state of affairs of the company and of the income and expenditure of the company for that year. In preparing those financial statements, the directors are required to: • select suitable accounting policies and then apply them consistently; • make judgements and estimates that are reasonable and prudent; and • prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The directors are responsible for keeping proper books of account which disclose with reasonable accuracy at any time the financial position of the company and to enable them to ensure that the financial statements are prepared in accordance with the accounting standards generally accepted in Ireland and comply with the Irish Companies Acts, 1963 to 1983 and 1990 to 2009. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. Going Concern Based on committed subscription fee income from stakeholder organisations over the next two years, the directors are satisfied that Animal Health Ireland Initiative has adequate resources to continue for at least 12 months from the date of approval of these financial statements and it is appropriate to adopt the going concern basis in the preparation of the financial statements. Books of Account The measures taken by the directors to secure compliance with the company’s obligations to keep proper books of account are the use of systems appropriate to the business and the employment of competent and reliable persons. Legal Status Animal Health Ireland Initiative is a company incorporated under the Companies Acts, 1963 to 1983 and 1990 to 2009 limited by guarantee and not having a share capital. Animal Health Ireland Initiative is a not for profit organisation set up to enhance value for livestock farmers and the agrifood industry through superior animal health. All income to the company is applied towards the running of the organisation. The directors confirm that they have complied with the above requirements in preparing the financial statements.

PAGE 27 Annua l R e p or t 2011

Directors’ Report (continued)

Directors The names of the persons who were directors at anytime during the period ended 31 st December 2011 are set out below. Unless indicated otherwise, they served as directors for the entire period. Mike Magan (Chairman)

Gerard Brickley John O’Sullivan

Laurence J. Collins Michael Doherty Robin Herbert Talbot Thia Hennessy (resigned 3rd July 2011) Principal Activities and Date of Incorporation

Animal Health Ireland Initiative was incorporated on 11 th May 2009 as a Company Limited by Guarantee and not having a share capital. Its principal activities are to promote awareness and education and to coordinate effective control programmes for non-regulated diseases of livestock. Results True results for the period are set out on pages 31 to 39. Subsequent Events There have been no significant events affecting the company since the period end. Transaction involving Directors There were no contracts of any significance in relation to the affairs of the company in which the directors had any interest, as defined in the Companies Acts, 1990, at any time during the year ending on 31 st December 2011. Auditors The auditors, Spain, Fewer Quinlan & Co., have indicated their willingness to continue in office in accordance with the provisions of Section 160(2) of the Companies Act, 1963.

On behalf of the Board Mike Magan

Robin Herbert Talbot



5th June 2012

PAGE 28 An i ma l H e a lt h I r e l and

We have audited the financial statements on pages 31 to 33 and the related Notes on pages 35 to 39. These financial statements have been prepared under the accounting policies set out on page 34. Respective responsibilities of directors and auditors The directors’ responsibilities for preparing the financial statements in accordance with the accounting standards issued by the Accounting Standards Board and published by The Institute of Chartered Accountants in Ireland (Generally Accepted Accounting Practice in Ireland) are set out in the Statement of Directors’ Responsibilities on pages 27 to 28. Our responsibility is to audit the financial statements in accordance with relevant legal and statutory requirements and International Standards on Auditing (UK and Ireland). This report, including the opinion, has been prepared for and only for the company’s members as a body in accordance with Section 193 of the Companies Act, 1990 and for no other purpose. We do not, in giving this opinion, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing. We report to you our opinion as to whether the financial statements give a true and fair view, in accordance with Generally Accepted Accounting Practice in Ireland applicable to, and are properly prepared in accordance with Irish statute comprising the Companies Acts, 1963 to 1983 and 1990 to 2009. We state whether we have obtained all the information and explanations we consider necessary for the purposes of our audit and whether the financial statements are in agreement with the books of account. We also report to you our opinion as to: Independent Auditors’ Report to the Members of Animal Health Ireland Initiative (A Company Limited by guarantee and not having a share capital) We also report to you if, in our opinion, any information specified by law regarding directors’ remuneration and directors’ transactions is not disclosed and, where practicable, include such information in our report. We read the directors’ report and consider the implications for our report if we become aware of any apparent misstatements within it. Basis of Audit Opinion We conducted our opinion in accordance with International Standards on Auditing (UK and Ireland) issued by the Auditing Practices Board. An audit includes examination, on a test basis, of evidence relevant to the amounts and disclosures in the financial statements. It also includes an assessment of the significant estimates and judgements made by the directors in the preparation of the financial statements, and of whether the accounting policies are appropriate to the company’s circumstances, consistently applied and adequately disclosed. We planned and performed our audit so as to obtain all the information and explanations which we consider necessary in order to provide us with sufficient evidence to give reasonable assurance that the financial statements are free from material misstatement, whether caused by fraud or other irregularity of error. In forming our opinion we also evaluated the overall adequacy of the presentation of information in the financial statements. • Whether the company has kept proper books of account; and • Whether the directors’ report is consistent with the financial statements.

PAGE 29 Annua l R e p or t 2011

Opinion In our opinion the financial statements: • give a true and fair view of the state of the company’s affairs at 31 January 2011 and of its income and expenditure for the year then ended, in accordance with Generally Accepted Practice in Ireland. • have been properly prepared in accordance with the Companies Acts, 1963 to 1983, and 1990 to 2009. We have obtained all the information and explanations we consider necessary for the purposes of our audit. In our opinion proper books of account have been kept by Animal Health Ireland. The financial statements are in accordance with the books of account. In our opinion the information given in the directors’ report on pages 27 to 28 is consistent with the financial statements. Independent Auditors’ Report to the Members of Animal Health Ireland Initiative (continued)

M.G Spain for and on behalf of Spain, Fewer Quinlan & Co. Chartered Accountants and Registered Auditors Thurles 5 th June 2012.

PAGE 30 An i ma l H e a lt h I r e l and

Income and Expenditure Account for the year ended 31st December 2011

11 Months to 31 Dec 2011

12 Months to 31 Jan 2011


€ 908,650 7,600 916,250 (892,537) 23,713 -

€ 645,681

Income from Stakeholders’ Subscriptions Other Income Total Income Operating Expenses Surplus on Ordinary Activities before Taxation Tax on Surplus on Ordinary Activities Surplus on Ordinary Activities after Taxation Retained Surplus/(Deficit) at beginning of financial year Retained Surplus/(Deficit) at end of financial year

645,681 (625,535) 20,146 -

2,3,4 5

23,713 45,415 69,128

20,146 25,269 45,415

There are no recognised gains or losses other than the surplus attributable to members of the Company for the above two financial years.

On behalf of the Board Mike Magan

Robin Herbert Talbot



PAGE 31 Annua l R e p or t 2011

Balance Sheet as at 31st December 2011

31 Dec 2011 31 Jan 2011


€ 16,688

€ 11,710

Fixed Assets Current Assets Debtors Cash at Bank


99,880 84,159 184,039 (131,599)

122,110 37,019 159,129 (125,424)


Creditors: amounts falling due within one year Net Current Assets Total Assets less Current Liabilities Creditors: amounts falling due greater than one year Total Net Assets Financed By: Revenue Reserves Account Member’s Funds


52,440 69,128 -

33,705 45,415 -

69,128 69,128 69,128

45,415 45,415 45,415


On behalf of the Board Mike Magan

Robin Herbert Talbot



PAGE 32 An i ma l H e a lt h I r e l and

Cashflow Statement for the period ended 31 December 2011

11 Months to 31 Dec 2011

12 Months to 31 Jan 2011


Reconciliation of Operating Surplus to Net Cash Inflow from Operating Activities Surplus on Ordinary Activities after Taxation Depreciation Decrease / (Increase) in operating debtors and prepayments Increase /(Decrease) in operating creditors and accruals

23,713 2,377 22,230 6,175

20,146 1,673 (112,354) (69,184)



Net Cash (Outflow)/Inflow from Operating Activities



Increase in Cash in Period from Operating Activities

Capital Expenditure and Financial Investment Payments to acquire tangible Fixed Assets (Decrease) / Increase in Cash (Decrease)/ Increase in cash in the year / period Opening Bank Balance at 1st February 2011 Closing Bank Balance at 31st December 2011



47,140 47,140 37,109 84,159

(173,102) (173,102) 210,121 37,019

PAGE 33 Annua l R e p or t 2011

Statement of Accounting Policies

The following accounting policies have been applied consistently in dealing with items which are con- sidered material in relation to the company’s financial statements. Accounting Convention Thefinancial statements arepreparedunder thehistorical cost convention inaccordancewithaccounting standards generally accepted in Ireland and Irish statute comprising the Companies Act 1963 to 2009. Accounting Standards generally accepted in Ireland in preparing financial statements giving a true and fair view are those issued by the Accounting Standards Board. The financial statements are expressed Income consists of stakeholders’ subscriptions. These funds are recognised in the financial statements on an accrual basis. Income received from stakeholders, including the Department of Agriculture, Food and the Marine (DAFM) is credited to the income and expenditure account so as to match it with the expenditure to which it relates. (Please also refer to policy on Government Grants). Government Grants Government grants are provided through the Department of Agriculture, Food and the Marine (DAFM) as annual stakeholder subscriptions to Animal Health Ireland Initiative (AHI). They are recognised in the profit and loss account to match them with the expenditure towards which they are intended to contribute. (Note - no government grants in respect of capital expenditure have been received to date by AHI.) Expenditure All expenditure to date has been written off and no value is attributed to unexpired costs or research projects completed to date. Fixed Assets & Depreciation Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost each asset systematically over its expected useful life, as follows: in Euro (€). Income

Office Equipment – 12.5% Straight Line Fixtures and Fittings – 12.5% Straight Line

PAGE 34 An i ma l H e a lt h I r e l and

Notes to the financial statements

Note 1 Going Concern Based on committed stakeholder subscriptions over the next two years and cash at bank, the directors are satisfied that Animal Health Ireland Initiative has adequate resources to continue for at least 12 months from the date of approval of these financial statements and it is appropriate to adopt the going concern basis in the preparation of the financial statements.

Note 2

Staff Costs

11 Months to Dec 2011

12 Months to Jan 2011

The staff costs for all employees are comprised of: Wages, Salaries and Social Welfare Costs

€ 214,767 112,145 326,912

€ 99,713 119,411 219,124

Other Staff Costs Total Staff Costs

The average number of people employed by the company during the period:-

Management Administration Project Management Planning & Operations Management Technical Working Group Liaison Total

1 1 1 1 1 5

Staff Costs have increased in the period to Dec 2011 due to the effect salary costs for the entire period for the Project Manager and Planning &Operations Manager. In the comparative period, these positions were only filled during the final Quarter of that Financial Year. In addition a Technical Working Group Liaison was recruited during the current period. Included under Other Staff Costs is the Department of Agriculture, Food and the Marine (DAFM) contribution towards the CEO’s salary and superannuation scheme. These costs form part of the DAFM’s overall annual contribution to the running of Animal Health Ireland Initiative, as set out in Note 3 below.

PAGE 35 Annua l R e p or t 2011

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41 Page 42

Made with FlippingBook - Online Brochure Maker